ADHD Medication Reduces Suicide and Crime Risks in Sweden, Study Reveals
New study finds ADHD medication lowers risks of suicide, substance abuse, and crime in Sweden.
- • ADHD medication reduces suicide attempts by 17% and crime by 13%.
- • About 200,000 people in Sweden are receiving ADHD treatment.
- • Methylphenidate is the most common ADHD medication in Sweden.
- • The study indicates benefits are more pronounced in those with a history of substance abuse and crime.
Key details
A recent comprehensive study published in the medical journal BMJ has highlighted the significant benefits of ADHD medication in reducing serious risks associated with suicide, substance abuse, and criminal behavior among individuals diagnosed with the disorder in Sweden. Conducted by a team of researchers including Professor Samuele Cortese from the University of Southampton and Zheng Chang from Karolinska Institute, the research studied nearly 150,000 newly diagnosed ADHD patients aged 6 to 64.
Key findings of the study indicate that treatment with ADHD medication, particularly methylphenidate—which is most commonly prescribed in Sweden—led to a 17% reduction in suicide attempts. Additionally, the risks of substance abuse and criminal behavior were reduced by 15% and 13%, respectively. Importantly, patients with prior histories of substance abuse and criminal activities experienced even more pronounced benefits, with a 25% reduction in these issues upon receiving medication.
The observational nature of the study acknowledges that while these associations are significant, definitive causal relationships cannot be affirmed. Nonetheless, the findings suggest that medication may improve attention and reduce impulsivity, thereby leading to better decision-making and a decrease in risky behaviors. About 200,000 individuals in Sweden currently receive ADHD medication, highlighting the relevance of this research for clinicians and patients alike.
Professor Cortese emphasized the importance of clinicians informing patients about both the benefits of medication and the risks associated with untreated ADHD, which can lead to increased likelihood of substance abuse and suicidal behavior. The study adds to the growing body of evidence about the positive impact of ADHD treatment on broader social outcomes, promoting discussions regarding the clinical management of ADHD in Sweden.